Erik Sulman
Overview
Explore the profile of Erik Sulman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meng Y, Bernstein K, Mashiach E, Santhumayor B, Kannapadi N, Gurewitz J, et al.
Neurosurgery
. 2024 Nov;
PMID: 39526756
Background And Objectives: The management of World Health Organization (WHO) grade 2 meningiomas is complicated by their diverse clinical behaviors. Stereotactic radiosurgery (SRS) can be an effective management option. Literature...
2.
Meng Y, Santhumayor B, Mashiach E, Bernstein K, Gurewitz J, Cooper B, et al.
Neurosurgery
. 2024 Aug;
96(3):622-629.
PMID: 39194227
Background And Objectives: Stereotactic radiosurgery (SRS) is effective for patients with medically refractory trigeminal neuralgia with a 75%-90% response rate. Consideration of the integral dose (ID) to the target nerve...
3.
Nuechterlein N, Shelbourn A, Szulzewsky F, Arora S, Casad M, Pattwell S, et al.
Genes Dev
. 2024 Apr;
38(5-6):273-288.
PMID: 38589034
Glioblastoma is universally fatal and characterized by frequent chromosomal copy number alterations harboring oncogenes and tumor suppressors. In this study, we analyzed exome-wide human glioblastoma copy number data and found...
4.
Schnurman Z, Mashiach E, Link K, Donahue B, Sulman E, Silverman J, et al.
Neurosurgery
. 2023 May;
93(5):986-993.
PMID: 37255296
Background And Objectives: Advances in targeted therapies and wider application of stereotactic radiosurgery (SRS) have redefined outcomes of patients with brain metastases. Under modern treatment paradigms, there remains limited characterization...
5.
Stitzlein L, Gangadharan A, Walsh L, Nam D, Espejo A, Singh M, et al.
Front Neurol
. 2023 Apr;
14:1112207.
PMID: 37082446
Introduction: Improved therapies for glioblastoma (GBM) are desperately needed and require preclinical evaluation in models that capture tumor heterogeneity and intrinsic resistance seen in patients. Epigenetic alterations have been well...
6.
Vogelbaum M, Brown P, Messersmith H, Brastianos P, Burri S, Cahill D, et al.
J Clin Oncol
. 2021 Dec;
40(5):492-516.
PMID: 34932393
Purpose: To provide guidance to clinicians regarding therapy for patients with brain metastases from solid tumors. Methods: ASCO convened an Expert Panel and conducted a systematic review of the literature....
7.
London D, Patel D, Donahue B, Navarro R, Gurewitz J, Silverman J, et al.
J Neurosurg
. 2021 Dec;
137(2):544-554.
PMID: 34891140
Objective: Patients with non-small cell lung cancer (NSCLC) metastatic to the brain are living longer. The risk of new brain metastases when these patients stop systemic therapy is unknown. The...
8.
Rahman R, Sulman E, Haas-Kogan D, Cagney D
Hematol Oncol Clin North Am
. 2021 Oct;
36(1):77-93.
PMID: 34711456
Radiation therapy has long been a critical modality of treatment of patients with central nervous system tumors, including primary brain tumors, brain metastases, and meningiomas. Advances in radiation technology and...
9.
Narayan R, Molenaar P, Teng J, Cornelissen F, Roelofs I, Menezes R, et al.
Nat Commun
. 2020 Jun;
11(1):2935.
PMID: 32523045
Personalized cancer treatments using combinations of drugs with a synergistic effect is attractive but proves to be highly challenging. Here we present an approach to uncover the efficacy of drug...
10.
Yeboa D, Yu J, Liao E, Huse J, Penas-Prado M, Kann B, et al.
Clin Transl Radiat Oncol
. 2019 Jan;
15:46-52.
PMID: 30656222
Molecular markers are redefining classification of lower grade gliomas and ushering in a paradigm shift in their management. Our objective was to evaluate the differences in pattern of care and...